Witness· Theranos
Surekha Gangakhedkar
Former Theranos scientist and team manager who led immunoassay development work.
AppearedFederal Criminal Trial
1,315 lines·5 appearances·20 mentions
About
Testified under immunity about Theranos assay development, unresolved device and validation problems, warnings to Holmes before the planned patient-testing launch, and her resulting resignation. Cross-examination established the limits of her research-and-development role while testing her accounts of information silos, validation, and prior successful assay work.
Trial Record (25)
FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022
Testimony (5)
Direct
Surekha Gangakhedkar — Direct
Day 8CrossSurekha Gangakhedkar — Cross
Day 8CrossSurekha Gangakhedkar — Cross
Day 9RedirectSurekha Gangakhedkar — Redirect
Day 9RedirectSurekha Gangakhedkar — Redirect (Resumed)
Day 9Mentioned (20)
Opening
Opening Statement by the Prosecution
Day 4ProceduralWitness Immunity Application and Ruling
Day 6ProceduralPretrial Evidentiary Hearing on Witness Testimony, Hearsay, and Immunity
Day 8ProceduralPretrial Evidentiary Hearing
Day 9ProceduralText Message Admissibility Hearing and Rulings
Day 10DirectAdam Rosendorff — Direct
Day 11CrossAdam Rosendorff — Cross
Day 12DirectVictoria Sung — Direct
Day 13CrossVictoria Sung — Cross
Day 13ProceduralDr. Dhawan Patient-Harm Testimony Dispute
Day 19ProceduralAdmissibility Hearing — Pfizer Internal Report
Day 21DirectDaniel Edlin — Direct
Day 21CrossDaniel Edlin — Cross
Day 22ProceduralParloff Interview Designation Four Evidentiary Hearing and Ruling
Day 35DirectElizabeth A. Holmes — Direct
Day 38ProceduralGovernment Motion to Exclude Late-Produced Documents
Day 42CrossElizabeth A. Holmes — Cross
Day 42Charge ConferenceFinal Jury Instructions Charge Conference Resumed
Day 44ClosingClosing Argument by the Prosecution
Day 46ClosingClosing Argument by the Defense — Continued
Day 47